ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 209

Focus on cardiovascular Risk Factor Recording In a Rheumatology Outpatient Clinic

Eirik Ikdahl1, Silvia Rollefstad2, Inge C. Olsen3, Tore K. Kvien4, Inger Johanne Widding Hansen5, Dag Magnar Soldal6, Glenn Haugeberg6 and Anne Grete Semb7, 1Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 2Rhuematology, Diakonhjemmet Hospital, Oslo, Norway, 3Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 4Faculty of Medicine, University of Oslo, Oslo, Norway, 5Hospital of Southern Norway Trust, Kristiansand, Norway, Kristiansand, Norway, 6Rheumatology, Hospital of Southern Norway Trust, Kristiansand, Norway, 7Preventive Cardio-Rheuma clinic, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Cardiovascular disease, rheumatoid arthritis (RA) and risk

  • Tweet
  • Email
  • Print
Session Information

Title: Health Services Research, Quality Measures and Quality of Care-Rheumatoid Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose: There is an unmet need of implementing the knowledge of cardiovascular (CV) risk in patients with rheumatoid arthritis (RA) into clinical practice. Our aim was to evaluate CV risk factor (CVRF) recording in a rheumatology outpatient clinic (ROC), where the standard was annual CVRF recording for all patients. Moreover, we evaluated how various clinical models influenced the extent of CVRF recording, comparing a regular ROC (RegROC) to an arthritis clinic (AC), a structured, team-based model.

Methods: Of the 1142 RA patients visiting ROC at the Hospital of Southern Norway during 2012, 612 attended RegROC and 530 attended the AC. Allocation to either RegROC or the AC was based on clinical judgement by the rheumatologist and did not include any inclusion criteria. For all patients, CVRFs were to be recorded in the medical journal as well as in a computerized journal program, GoTreatIT-rheuma (GTI-r). We searched both journal systems to ascertain how many patients had CVRFs recorded.

Results: Overall, 38.2% of patients had CVRFs recorded and only 26.9% had recorded all the CVRFs included in the CV risk calculator, SCORE. When comparing the AC to the RegROC, odds ratios (OR) for CVRFs being recorded in the medical journal was for: lipids: 5.0-6.0, blood pressure (BP): 12.4, glucose: 9.1, and HbA1c: 6.1 (p for all < 0.001)(Table). In the GTI-r journal the discrepancies between the AC and RegROC were even more pronounced. OR for CVRFs being recorded was for lipids: 15.9, BP: 27.5 and for having recorded all the CVRFs included in SCORE: 21.0 (p for all < 0.001).

Conclusion: Despite high focus on CV disease, recording of CVRFs in the ROC was low; however it was augmented, but still not satisfactory in a structured, team-based model. There is necessity for improving systems for CVRF recording in patients with RA.

Table: Cardiovascular risk factors recorded in patients attending rheumatology consultations in a rheumatology outpatient clinic

Cardiovascular

Risk factors

ROC

(n=1142)

AC

(n=530)

RegROC

(n=612)

OR*

(95% CI)

AC vs. RegROC

P-value*

Medical journal: n (%)

Brachial BP   

576 (50.4)

421 (79.4)

155 (25.3)

12.36 (9.27, 16.48)

< 0.001

Total cholesterol

537(47.0)

354 (66.8)

183 (29.9)

5.02 (3.89, 6.48)

< 0.001

LDL-cholesterol

503 (44.1)

347 (65.5)

156 (25.5)

5.87 (4.53, 7.62)

< 0.001

HDL-cholesterol

515 (45.1)

350 (66.0)

165 (27.0)

5.59 (4.31, 7.23)

< 0.001

Triglycerides

472 (41.3)

333 (62.8)

139 (22.7)

6.02 (4.63, 7.82)

< 0.001

Fasting blood glucose

351 (30.7)

281 (53.0)

70 (11.4)

9.11 (6.71, 12.35)

< 0.001

HbA1c

385 (33.7)

284 (53.6)

101 (16.5)

6.10 (4.62, 8.04)

< 0.001

GTI-r journal n (%)

Brachial BP

422 (37.0)

371 (70.0)

51 (8.3)

27.46 (19.41, 38.85)

< 0.001

Lipid values

378 (33.1)

321 (60.6)

57 (9.3)

15.90 (11.45, 22.08)

< 0.001

Smoking

756 (66.2)

378 (69.3)

378 (61.8)

1.44 (1.12, 1.85)

0.05

Complete risk profile

307 (26.9)

276 (52.1)

31 (5.1)

20.97 (14.04, 31.33)

< 0.001

CV medication

251 (22.0)

198 (37.4)

53 (8.7)

6.31 (4.52, 8.82)

< 0.001

CV co-morbidities

231 (20.2)

184 (34.7)

47 (7.7)

6.43 (4.53, 9.14)

< 0.001

*Adjusted for age and gender

ROC: rheumatology outpatient clinic, RegROC: Regular rheumatology outpatient clinic, AC: Arthritis clinic, CV: Cardiovascular, LDL: Low-density lipoprotein, HDL: High-density lipoprotein, BP: Blood pressure, HbA1c: Glycated haemoglobin, GTI-r: GoTreatIT-rheuma, Complete risk profile: Complete lipid values, smoking and blood pressure, CV medication: Anti-hypertensive and statins, CV co-morbidities: Hypertension, angina pectoris, acute myocardial infarction, percutaneous coronary intervention, coronary artery bypass graft surgery, cerebrovascular accident, premature familiar cardiovascular disease


Disclosure:

E. Ikdahl,
None;

S. Rollefstad,
None;

I. C. Olsen,
None;

T. K. Kvien,
None;

I. J. W. Hansen,
None;

D. M. Soldal,
None;

G. Haugeberg,
None;

A. G. Semb,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/focus-on-cardiovascular-risk-factor-recording-in-a-rheumatology-outpatient-clinic/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology